Angiogenesis Inhibition (Recent Results in Cancer Research, Band 180) - Softcover

Buch 10 von 157: Recent Results in Cancer Research
 
9783642261435: Angiogenesis Inhibition (Recent Results in Cancer Research, Band 180)
Softcover
ISBN 10: 3642261434 ISBN 13: 9783642261435
Verlag: Springer, 2012

Inhaltsangabe

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Von der hinteren Coverseite

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies.

This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
Springer
Erscheinungsdatum
2012
Sprache
Englisch
ISBN 10 
3642261434
ISBN 13 
9783642261435
Einband
Taschenbuch
Anzahl der Seiten
248
Herausgeber
Liersch Rüdiger, Berdel Wolfgang E., Kessler Torsten
Kontakt zum Hersteller
Springer Nature Customer Service Center GmbH
ProductSafety@springernature.com

Europaplatz 3
Heidelberg
69115
Deutschland

Weitere beliebte Ausgaben desselben Titels

9783540782803: Angiogenesis Inhibition (Recent Results in Cancer Research, 180, Band 180)

Vorgestellte Ausgabe

ISBN 10:  354078280X ISBN 13:  9783540782803
Verlag: Springer, 2009
Hardcover